"Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge" by Amy Starosciak

Selected Works of Felipe de los Rios La Rosa

Presentation

Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge

All Publications

Amy Starosciak, Miami Cancer Institute
Felipe De Los Rios La Rosa, Miami Neuroscience Institute

Download

Publication Date

4-1-2019

Presented At:

QCOR 2019 Scientific Sessions

Content Type

application/pdf

Additional Authors:

Additional authors and institutional affiliations

Disciplines

Cardiology,
Cardiovascular Diseases,
Diseases,
Medicine and Health Sciences,
Nervous System Diseases and
Neurology

Citation Information

Amy Starosciak and Felipe De Los Rios La Rosa. "Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge" (2019)
Available at: http://works.bepress.com/felipe-delosrioslarosa/12/